Advanced in Breast Cancer

Takuhiro Yamaguchi

Sendai, JP 
Advanced in Breast Cancer
Sendai, JP 
OverviewLocationsClinical Research

Overview

Takuhiro Yamaguchi practices in Sendai, Japan. Yamaguchi is rated as an Advanced expert by MediFind in the treatment of Breast Cancer. Their top areas of expertise are Musculocontractural Ehlers-Danlos Syndrome (mcEDS), Ehlers-Danlos Syndrome (EDS), Adult T-Cell Leukemia, Endoscopy, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 439 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 28 articles in the study of Breast Cancer.

Locations

Sendai, 9808574, Japan
Other Locations
Sakai, 5998531, Japan
Saitama, 3388570, Japan
Tokyo, Japan
Tsukuba, Japan
Japan
Yamaguchi, Japan
Ariake, 1358550, Japan
Research Field In Dentistry, Kagoshima, Japan
Osaka, Japan
Tohoku, Japan
Kyoto, Japan
Hiroshima, 7398527, Japan
Hori, 5340021, Japan
Maebashi, Japan
Matsumoto, Japan
Koganei, 1840003, Japan
Chiba, Japan
Sagamihara, 2525210, Japan
Hongo, 1138655, Japan
Kanagawa, Japan
Nanakuma, 8140180, Japan
Kurume, Japan
Inage, 2638522, Japan
Kitakyushu, Japan
Ebetsu, 0698501, Japan
Tsu, Japan
Hayama, 2400193, Japan
Kanazawa, Japan
Chuo, 2608717, Japan
Nagoya, Japan
Fuji, Japan
Nagaoka, 9402188, Japan
Kashiwa, 2778561, Japan
Date, 9402188, Japan
Fushimi, 6128555, Japan
Kinoshita, Japan
Nagasaki, Japan
Tsushima, Japan
Tochigi, Japan
Kimiidera, 6418510, Japan
Sapporo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

441 Total Publications

Correction: Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Correction: Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Journal: Clinical and experimental nephrology
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamaguchi's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 83 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile